{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:51:25Z","timestamp":1769197885780,"version":"3.49.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union and the European Reginal Development Fund","award":["GINOP-2.3.2-15-2016-00043"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00043"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197890","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T17:28:19Z","timestamp":1528738099000},"page":"e0197890","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting"],"prefix":"10.1371","volume":"13","author":[{"given":"Zsolt","family":"Fejes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Czimmerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Sz\u00fck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szil\u00e1rd","family":"P\u00f3liska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enik\u0151","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikt\u00f3ria","family":"Jeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"V\u00e1radi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"Fenyvesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"\u00c9des","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Kappelmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-3267","authenticated-orcid":true,"given":"B\u00e9la","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/S0140-6736(08)60922-8","article-title":"Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis","volume":"371","author":"AA Bavry","year":"2008","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"MA Costa","year":"2005","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.coph.2004.10.004","article-title":"Insulin resistance, hyperleptinemia and endothelial dysfunction in coronary restenosis","volume":"5","author":"P Piatti","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1378\/chest.07-1693","article-title":"Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage\/dysfunction","volume":"132","author":"CJ Boos","year":"2007","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-010-0471-7","article-title":"Inflammatory response to percutaneous coronary intervention in stable coronary artery disease","volume":"31","author":"PS Munk","year":"2011","journal-title":"J Thromb Thrombol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/09537104.2015.1112368","article-title":"Integrity(<sup>\u00ae<\/sup>) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(<sup>\u00ae<\/sup>) everolimus-eluting stents in stable angina patients","volume":"27","author":"T Sz\u00fck","year":"2016","journal-title":"Platelets"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood.V84.7.2068.2068","article-title":"Leukocyte-endothelial adhesion molecules","volume":"84","author":"TM Carlos","year":"1994","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/clc.20815","article-title":"Soluble receptors for advanced glyca- tion end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention","volume":"33","author":"ED McNair","year":"2010","journal-title":"Clin Cardiol"},{"key":"ref9","first-page":"317","article-title":"Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes","volume":"8","author":"VF Panoulas","year":"2015","journal-title":"Med Devices (Auckl)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/cmi.2014.24","article-title":"Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation","volume":"12","author":"D Vitiello","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.20131125","article-title":"Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2","volume":"211","author":"C Wang","year":"2014","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCRESAHA.111.247445","article-title":"MicroRNAs in vascular and metabolic disease","volume":"110","author":"A Zampetaki","year":"2012","journal-title":"Circ Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.111.037572","article-title":"Transcoronary concentration gradients of circulating microRNAs","volume":"124","author":"S De Rosa","year":"2011","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvt161","article-title":"MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease","volume":"100","author":"M Hulsmans","year":"2013","journal-title":"Cardiovasc Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e112043","DOI":"10.1371\/journal.pone.0112043","article-title":"Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis","volume":"9","author":"M He","year":"2014","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1172\/JCI76069","article-title":"A selective microRNA-based strategy inhibits restenosis while preserving endothelial function","volume":"124","author":"G Santulli","year":"2014","journal-title":"J Clin Invest"},{"key":"ref17","first-page":"1973","article-title":"MicroRNA-181b regulates NF-\u03baB-mediated vascular inflammation","volume":"122","author":"X Sun","year":"2012","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V100.3.879","article-title":"Pro-oxidant and cytotoxic effects of circulating heme","volume":"100","author":"V Jeney","year":"2002","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e0170537","DOI":"10.1371\/journal.pone.0170537","article-title":"Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers","volume":"12","author":"J V\u00e1radi","year":"2017","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"H Thorvaldsdottir","year":"2012","journal-title":"Brief Bioinform"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molcel.2014.08.024","article-title":"NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis","volume":"56","author":"JD Brown","year":"2014","journal-title":"Mol Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1160\/TH16-04-0322","article-title":"Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus","volume":"117","author":"Z Fejes","year":"2017","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e55168","DOI":"10.1371\/journal.pone.0055168","article-title":"A versatile method to design stem-loop primer-based quantitative PCR assays for detecting small regulatory RNA molecules","volume":"8","author":"Z Czimmerer","year":"2013","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/cvr\/cvq050","article-title":"ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration","volume":"86","author":"S Hortelano","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbagrm.2016.02.004","article-title":"Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation","volume":"1859","author":"Q Duan","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbagrm.2017.11.003","article-title":"Dynamic transcriptional control of macrophage miRNA signature via inflammation responsive enhancers revealed using a combination of next generation sequencing-based approaches","volume":"1861","author":"Z Czimmerer","year":"2018","journal-title":"Biochim Biophys Acta"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.immuni.2017.12.010","article-title":"The Transcription factor STAT6 mediates direct repression of inflammatory enhancers and limits activation of alternatively polarized macrophages","volume":"48","author":"Z Czimmerer","year":"2018","journal-title":"Immunity"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-016-0390-9","article-title":"Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells","volume":"15","author":"L La Sala","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cbin.10572","article-title":"MicroRNA-185 inhibits angiogenesis in human microvascular endothelial cells through targeting stromal interaction molecule 1","volume":"40","author":"J Hou","year":"2016","journal-title":"Cell Biol Int"},{"issue":"Pt A","key":"ref30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2015.10.017","article-title":"MiRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration","volume":"89","author":"Q Chen","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/09537100903477582","article-title":"Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone","volume":"21","author":"B Nagy Jr","year":"2010","journal-title":"Platelets"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbapap.2006.04.018","article-title":"Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury","volume":"1774","author":"M Buerke","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"M Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2009.01.072","article-title":"Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation","volume":"53","author":"H Ota","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref35","unstructured":"Abbott Vascular XIENCE<sup>\u00ae<\/sup> Alpine Everolimus Eluting Coronary Stent Systems. EL2099886, 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.vascular.abbott\/us\/products\/coronary-intervention\/xience-alpine-drug-eluting-stent.html\" xlink:type=\"simple\">https:\/\/www.vascular.abbott\/us\/products\/coronary-intervention\/xience-alpine-drug-eluting-stent.html<\/ext-link>"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbrc.2013.11.092","article-title":"TNF\u03b1 induces the expression of genes associated with endothelial dysfunction through p38MAPK-mediated down-regulation of miR-149","volume":"443","author":"D Palmieri","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/jcmm.13074","article-title":"Overexpression of microRNA-138 alleviates human coronary artery endothelial cell injury and inflammatory response by inhibiting the PI3K\/Akt\/eNOS pathway","volume":"21","author":"JB Li","year":"2017","journal-title":"J Cell Mol Med"},{"key":"ref38","first-page":"5308170","article-title":"NF-\u03baB-Regulated miR-99a Modulates Endothelial Cell Inflammation","volume":"2016","author":"MH Bao","year":"2016","journal-title":"Mediators Inflamm"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1160\/TH11-12-0826","article-title":"The role of microRNAs in arterial remodelling","volume":"107","author":"M Nazari-Jahantigh","year":"2012","journal-title":"Thromb Haemost"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/ncomms4292","article-title":"HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells","volume":"5","author":"F Tabet","year":"2014","journal-title":"Nat Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"H1303","DOI":"10.1152\/ajpheart.00290.2015","article-title":"MicroRNA-141 regulates the expression level of ICAM-1 on endothelium to decrease myocardial ischemia-reperfusion injury","volume":"309","author":"RR Liu","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"48145","DOI":"10.18632\/oncotarget.18308","article-title":"Circulating microRNAs as potential biomarkers for coronary plaque rupture","volume":"8","author":"S Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCRESAHA.113.302089","article-title":"Systemic delivery of microRNA-181b inhibits nuclear factor-\u03baB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice","volume":"114","author":"X Sun","year":"2014","journal-title":"Circ Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/ATVBAHA.115.305597","article-title":"Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis","volume":"35","author":"D Wang","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.115.308237","article-title":"MicroRNAs for Restenosis and Thrombosis After Vascular Injury","volume":"118","author":"C Gareri","year":"2016","journal-title":"Circ Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e0172798","DOI":"10.1371\/journal.pone.0172798","article-title":"Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model","volume":"12","author":"M Izuhara","year":"2017","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T10:04:03Z","timestamp":1604397843000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197890"}},"subtitle":[],"editor":[{"given":"Maria Fiammetta","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197890","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]}}}